BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36453956)

  • 21. [Analysis of genetic variants in a patient with Familial hemophagocytic lymphohistiocytosis].
    Zhang Z; Yu X; Wang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Mar; 40(3):282-286. PubMed ID: 36854401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.
    Pisciotta L; Priore Oliva C; Cefalù AB; Noto D; Bellocchio A; Fresa R; Cantafora A; Patel D; Averna M; Tarugi P; Calandra S; Bertolini S
    Atherosclerosis; 2006 Jun; 186(2):433-40. PubMed ID: 16183066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of phenotype and genetic variant in a family with Shprintzen-Goldberg syndrome].
    Shi J; Sun J; Chen Y; Zhu M; Wang Q; Lu C; Wang D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jul; 39(7):703-707. PubMed ID: 35810425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and genetic analysis of a patient with Loeys-Dietz syndrome due to variant of TGFBR2 gene].
    Wang Y; Kong Z; Wan L; Wang A; Li X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Dec; 40(12):1531-1535. PubMed ID: 37994137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of SIFD syndrome caused by novel compound heterozygous variants of TRNT1 gene].
    Wang J; He X; Chen D; Hang S; Gao Y; Li X; Hu K; Bai C; Chen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):977-980. PubMed ID: 34625936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
    Chora JR; Medeiros AM; Alves AC; Bourbon M
    Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein structural insights into a rare PCSK9 gain-of-function variant (R496W) causing familial hypercholesterolemia in a Saudi family: whole exome sequencing and computational analysis.
    Shaik NA; Al-Shehri N; Athar M; Awan A; Khalili M; Al Mahadi HB; Hejazy G; Saadah OI; Al-Harthi SE; Elango R; Banaganapalli B; Alefishat E; Awan Z
    Front Physiol; 2023; 14():1204018. PubMed ID: 37469559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
    Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
    Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of six uncharacterised mutations in LDLR gene.
    Gomez A; Colombo R; Pontoglio A; Helman L; Kaeser L; Giunta G; Parolin ML; Toscanini U; Cuniberti L
    Atherosclerosis; 2019 Dec; 291():44-51. PubMed ID: 31689621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
    Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
    J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.
    Rodríguez-Jiménez C; Pernía O; Mostaza J; Rodríguez-Antolín C; de Dios García-Díaz J; Alonso-Cerezo C; García-Polo I; Blanco A; Lahoz C; Arrieta F; Beltrán L; Díaz de Bustamante A; Garzón-Lorenzo L; Álvarez-Sala LA; Asenjo Á; Ibáñez de Cáceres I; Rodríguez-Nóvoa S
    Hum Mutat; 2019 Aug; 40(8):1181-1190. PubMed ID: 31106925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
    Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
    J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.
    Jiang L; Benito-Vicente A; Tang L; Etxebarria A; Cui W; Uribe KB; Pan XD; Ostolaza H; Yang SW; Zhou YJ; Martin C; Wang LY
    Atherosclerosis; 2017 Aug; 263():163-170. PubMed ID: 28645073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia.
    Michikura M; Hori M; Ogura M; Hosoda K; Harada-Shiba M
    Atherosclerosis; 2022 Oct; 358():41-46. PubMed ID: 36087353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of RUNX2 gene variant in a Chinese patient with cleidocranial dysplasia].
    Yuan H; Wang Y; Wang Q; Luo S; Liu C; Yuan H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):749-752. PubMed ID: 34365616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel LDLR variants in patients with familial hypercholesterolemia: in silico analysis as a tool to predict pathogenic variants in children and their families.
    Mollaki V; Progias P; Drogari E
    Ann Hum Genet; 2013 Sep; 77(5):426-34. PubMed ID: 23815734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the gene defect responsible for severe hypercholesterolaemia using whole-exome sequencing.
    Sun LY; Zhang YB; Jiang L; Wan N; Wu WF; Pan XD; Yu J; Zhang F; Wang LY
    Sci Rep; 2015 Jun; 5():11380. PubMed ID: 26077743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.